Vidan Diagnostics Makes β-Hydroxybutyrate 21 FS Assay Available on Beckman Coulter DxC 500i Clinical Analyzer

SAN ANTONIO, Texas — August 6, 2026 — Vidan Diagnostics today announced that its reagent application for the β-Hydroxybutyrate 21 FS Assay is now available for the Beckman Coulter DxC 500i Clinical Analyzer. The β-Hydroxybutyrate 21 FS Assay is intended for the quantitative in vitro determination of β-hydroxybutyrate (BHB) in human serum and plasma on photometric systems. BHB is a critical biological marker when used in conjunction with clinical findings and other laboratory tests for the diagnosis and management of ketoacidosis and its primary causative factor, diabetic ketoacidosis (DKA).

Extended Stability and Seamless Integration

The β-Hydroxybutyrate 21 FS Assay is a liquid-stable, ready-to-use reagent that offers eight weeks of calibration and onboard stability when run on the Beckman Coulter DxC 500i Clinical Analyzer.

“Beckman Coulter continues to advance laboratory capabilities across the United States by utilizing standardized reagents and consumables across its scalable diagnostic portfolio,” stated Gilbert Mejia, CEO of Vidan Diagnostics. “This consistency provides platforms like the DxC 500i with commutable patient results, offering healthcare networks substantial strategic advantages in patient care. Furthermore, our β-Hydroxybutyrate 21 FS assay remains the preferred choice for Beckman users and field application specialists due to its distinct performance benefits and convenient, prefilled bottles that load directly onto Beckman Coulter chemistry systems.”

The Importance of Beta-Hydroxybutyrate in DKA Diagnosis

Beta-hydroxybutyrate is the predominant ketone body produced during diabetic ketoacidosis. Its relative proportion in the blood (78%) is significantly greater than the other two ketones, acetoacetate (20%) and acetone (2%), making it the most reliable indicator of DKA. DKA is a life-threatening medical emergency that can lead to diabetic coma or death if left unmanaged.

About Vidan Diagnostics

Founded in 2018, Vidan Diagnostics is a dedicated supplier of medical diagnostic products, focusing on medical devices and reagents used to diagnose and monitor diabetes, sepsis, anemia, heart disease, and stroke. The company is committed to delivering proven and innovative diagnostics with integrity and reliability to healthcare facilities worldwide. Vidan Diagnostics is headquartered in San Antonio, Texas.